Patents-Review.com
🔗 Permalink
Assignee profile:

Synthorx, Inc.

City:

La Jolla, California

Country:

United States

Published Applications:

24

Last publication date:

2025-05-15

Patent Grants:

10

Last grant date:

2025-06-03

Top Inventors for applications by Synthorx, Inc.

These are the the leading inventors for applications assigned to Synthorx, Inc.:

Recent patent applications by Synthorx, Inc.

Synthorx, Inc. based in La Jolla, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-05-15
US20250154218A1
Chemistry; metallurgy

IL-2 Conjugates and Methods of Use to Treat Autoimmune Diseases

 #2 | 2025-03-06
US20250075276A1
Chemistry; metallurgy

METHODS FOR SELECTING SUBJECTS AND TREATING CANCER WITH IL-2 THERAPY

 #3 | 2024-11-21
US20240383957A1
Chemistry; metallurgy

IL-15 Conjugates and Uses Thereof

 #4 | 2024-08-29
US20240287151A1
Chemistry; metallurgy

IL-15 Conjugates and Uses Thereof

 #5 | 2024-07-11
US20240226309A1
Human necessities

HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB

 #6 | 2024-03-14 ✅ Patent 12,318,431 granted on 2025-06-03
US20240082359A1
Human necessities

Cytokine conjugates for the treatment of proliferative and infectious diseases

 #7 | 2023-12-28
US20230416327A1
Chemistry; metallurgy

IMMUNO ONCOLOGY THERAPIES WITH IL-2 CONJUGATES

 #8 | 2023-09-28
US20230302089A1
Human necessities

CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES

 #9 | 2023-09-07
US20230277627A1
Human necessities

IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND PEMBROLIZUMAB

 #10 | 2022-10-13
US20220324792A1
Chemistry; metallurgy

METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE

 #11 | 2022-09-01
US20220273767A1
Human necessities

Interleukin 10 Conjugates and Uses Thereof

 #12 | 2022-01-20
US20220016252A1
Human necessities

IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES

 #13 | 2022-01-20
US20220016249A1
Human necessities

IL-2 Conjugates and Methods of Use Thereof

 #14 | 2021-11-04
US20210338829A1
Human necessities

INTERLEUKIN 10 CONJUGATES AND USES THEREOF

 #15 | 2021-07-22 ✅ Patent 11,834,689 granted on 2023-12-05
US20210222147A1
Chemistry; metallurgy

Incorporation of unnatural nucleotides and methods thereof

 #16 | 2021-03-11 ✅ Patent 12,234,271 granted on 2025-02-25
US20210070827A1
Chemistry; metallurgy

Il-2 conjugates and methods of use to treat autoimmune diseases

 #17 | 2021-02-25 ✅ Patent 12,344,648 granted on 2025-07-01
US20210054040A1
Chemistry; metallurgy

NOVEL IL-15 CONJUGATES AND USES THEREOF

 #18 | 2021-02-18
US20210046160A1
Human necessities

Immuno Oncology Combination Therapies With IL-2 Conjugates

 #19 | 2020-12-24 ✅ Patent 11,919,934 granted on 2024-03-05
US20200399338A1
Chemistry; metallurgy

IL-15 conjugates and uses thereof

 #20 | 2020-10-22 ✅ Patent 11,077,195 granted on 2021-08-03
US20200330601A1
Human necessities

IL-2 conjugates and methods of use thereof

 #21 | 2020-07-23 ✅ Patent 11,622,993 granted on 2023-04-11
US20200231644A1
Chemistry; metallurgy

Cytokine conjugates for the treatment of autoimmune diseases

 #22 | 2020-06-18 ✅ Patent 11,701,407 granted on 2023-07-18
US20200188484A1
Human necessities

Cytokine conjugates for the treatment of proliferative and infectious diseases

 #23 | 2019-10-17 ✅ Patent 10,610,571 granted on 2020-04-07
US20190314455A1
Human necessities

Cytokine conjugates for the treatment of proliferative and infectious diseases

 #24 | 2016-06-16 ✅ Patent 10,626,138 granted on 2020-04-21
US20160168187A1
Chemistry; metallurgy

Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

Also check out Synthorx, Inc.'s (La Jolla, United States) applicant profile with 15 patent applications submitted.

AssigneeID:

109502 ⎘